从Bacillus subtilis菌株2i中在浸泡发酵下优化粉酶的生产和表征
Maryam Kainat1, Dian Nugraheni2, Titin Haryati3
1Department of Biotechnology, University of Sargodha, Sargodha, Pakistan.
Journal of microbiological methods
|March 5, 2026
概括
这项研究优化了使用Bacillus subtilis和果核的粉酶生产. 增强的酶在洗剂中表现出稳定性,这表明工业应用的潜力.
科学领域:
- 生物技术是生物技术.
- 酵素工程是什么意思 酵素工程
背景情况:
- 氨基酶对于工业生物技术至关重要.
- 细菌细菌是酶生产的关键微生物.
研究的目的:
- 用果核优化Bacillus subtilis 2i菌株的粉酶生产.使用果核.
- 为了表征产生的氨酶,用于工业应用.
主要方法:
- 使用Plackett-Burman设计 (PBD) 和响应表面方法 (RSM) 与中央复合设计 (CCD) 的统计优化.
- 浸泡发酵技术. 在水中发酵.
- 酶表征包括最佳温度,pH和稳定性研究.
主要成果:
- 确定了 (NH4) 2SO4,MgSO4和FeSO4作为优化的重要变量.
- 在70°C和pH8下确定最佳活性.
- 观察到Ca2 +,Mn2 +,甲醇和乙的增强活性;SDS显示抑制.
- 计算的热力学参数:Ea = 13.7 kJ/mol, ΔH = 10.63 kJ/mol, ΔS = 0.079 kJ·mol−1·K−1.1. 这些参数为:
结论:
- 优化粉酶的生产是可行的使用果核.
- 描述的氨酶在各种表面活性剂和洗剂中表现出稳定性.
- 该酶适合纳入商业洗剂配方和其他工业过程.
更多相关视频
06:24Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology
Published on: December 15, 2017
10.8K
06:08Design of Solid-State Fermentation Systems for Polymer Hydrolytic Extracellular Enzyme Production by Filamentous Fungi
Published on: June 6, 2025
1.5K
相关概念视频
Bioreactor Controls-II
In aerobic fermentations, oxygen is vital for microbial growth and metabolite production. Since air comprises only about 20% oxygen and the gas is poorly soluble in water—just 9 ppm at 20°C—supplying sufficient oxygen becomes a critical challenge, especially in high-demand processes like yeast growth or citric acid production. Even a fully saturated broth may offer only a few seconds of oxygen availability.To address this, sterile or scrubbed air is introduced into the fermentor via a sparger...
Bioreactor Controls-III
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
Upstream Processing
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
Production of Organic Acids
Lactic acid, an important organic acid extensively applied in food, pharmaceutical, and biodegradable polymer industries, is primarily produced via microbial fermentation. This method is favored over chemical synthesis due to its environmental sustainability and capacity for enantiomerically pure product formation. Among various microbial processes, the fermentation of starch-based substrates stands out due to the abundance and renewability of raw materials like corn and potatoes.Hydrolysis of...
Production of Antibiotics
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
